Watch List: American Diversified Holdings (OTCMKTS:ADHC), Oncomed Pharmaceuticals (NASDAQ:OMED), Concert Pharmaceuticals (NASDAQ:CNCE), Actinium Pharmaceuticals (NYSEMKT:ATNM)

American Diversified Holdings Corp (OTCMKTS:ADHC) stock performance was -16.67% in last session and finished the day at $0.0375. Traded volume was 506,482.00million shares in the last session. The beta of the stock remained 3.20.

OncoMed Pharmaceuticals Inc said it halted patient enrollment and dosing in all ongoing early-stage trials of two of its experimental cancer drugs over concerns of bone damage. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) dropped -5.76 percent to $23.09Monday on volume of 190,309.00million shares. The intra-day range of the stock was $23.02 to $24.49. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) has a market capitalization of $682.27million.

Equities researchers at Roth Capital started coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE) in a research report issued on Thursday. The firm set a “buy” rating and a $28.00 price target on the stock. Roth Capital’s price target indicates a potential upside of 216.74% from the company’s current price. Concert Pharmaceuticals Inc (NASDAQ:CNCE)’s stock on June 23, 2014 reported a decrease of -8.60% to the closing price of $9.56. Its fifty two weeks range is $7.12-$16.26. The total market capitalization recorded $171.12million. The overall volume in the last trading session was 186,733.00million shares. In its share capital, CNCE has 17.90million outstanding shares.

Actinium Pharmaceuticals Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”) a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers is set to join the broad-market Russell 3000® Index as well as the Russell 2000®Russell Global and Russell Microcap® indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27 according to a preliminary list of additions posted June 13 on www.russell.com/indexes. Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) stock performance was -10.07% in last session and finished the day at $8.84. Traded volume was 169,394.00million shares in the last session and the average volume of the stock remained 66.74K shares. The beta of the stock remained 17.80.